BOTULINUM NEUROTOXIN B ENGINEERED FOR INCREASED RECEPTOR AFFINITY HAS IMPROVED CLINICAL POTENTIAL

被引：1
|
作者：
Elliott, Mark [1 ]
Favre-Guilmard, Christine [2 ]
Liu, Sai Man [1 ]
Maignel, Jacquie [2 ]
Masuyer, Geoffrey [3 ]
Beard, Matthew [1 ]
Boone, Christopher [4 ]
Carre, Denis [2 ]
Kalinichev, Mikhail [2 ]
Lezmi, Stephane
Mir, Imran
Nicoleau, Camille [2 ]
Palan, Shilpa [1 ]
Perier, Cindy [2 ]
Raban, Elsa [2 ]
Zhang, Sicai
Dong, Min [4 ]
Stenmark, Pal
Krupp, Johannes [1 ,2 ]
机构：
[1] Ipsen Biolnnovat, Abingdon, Oxon, England
[2] Ipsen Innovat, 5 Ave Canada, F-91940 Les Ulis, France
[3] Stockholm Univ, Stockholm, Sweden
[4] Boston Childrens Hosp, Boston, MA USA
来源：
TOXICON | 2018年 / 156卷
关键词：
D O I：
10.1016/j.toxicon.2018.11.070
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
60
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
    Elliott, Mark
    Favre-Guilmard, Christine
    Liu, Sai Man
    Maignel, Jacquie
    Masuyer, Geoffrey
    Beard, Matthew
    Boone, Christopher
    Carre, Denis
    Kalinichev, Mikhail
    Lezmi, Stephane
    Mir, Imran
    Nicoleau, Camille
    Palan, Shilpa
    Perier, Cindy
    Raban, Elsa
    Zhang, Sicai
    Dong, Min
    Stenmark, Pal
    Krupp, Johannes
    SCIENCE ADVANCES, 2019, 5 (01)
  • [2] Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
    Tao, Liang
    Peng, Lisheng
    Berntsson, Ronnie P. -A.
    Liu, Sai Man
    Park, SunHyun
    Yu, Feifan
    Boone, Christopher
    Palan, Shilpa
    Beard, Matthew
    Chabrier, Pierre-Etienne
    Stenmark, Pal
    Krupp, Johannes
    Dong, Min
    NATURE COMMUNICATIONS, 2017, 8
  • [3] Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
    Liang Tao
    Lisheng Peng
    Ronnie P.-A. Berntsson
    Sai Man Liu
    SunHyun Park
    Feifan Yu
    Christopher Boone
    Shilpa Palan
    Matthew Beard
    Pierre-Etienne Chabrier
    Pål Stenmark
    Johannes Krupp
    Min Dong
    Nature Communications, 8
  • [4] Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
    Jin, Rongsheng
    Rummel, Andreas
    Binz, Thomas
    Brunger, Axel T.
    NATURE, 2006, 444 (7122) : 1092 - 1095
  • [5] Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
    Rongsheng Jin
    Andreas Rummel
    Thomas Binz
    Axel T. Brunger
    Nature, 2006, 444 : 1092 - 1095
  • [6] Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: Increased therapeutic dosage and immunogenicity
    Strotmeier, Jasmin
    Willjes, Gesche
    Binz, Thomas
    Rummel, Andreas
    FEBS LETTERS, 2012, 586 (04) : 310 - 313
  • [7] Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety
    Vazquez-Cintron, Edwin
    Tenezaca, Luis
    Angeles, Christopher
    Syngkon, Aurelia
    Liublinska, Victoria
    Ichtchenko, Konstantin
    Band, Philip
    SCIENTIFIC REPORTS, 2016, 6
  • [8] Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety
    Edwin Vazquez-Cintron
    Luis Tenezaca
    Christopher Angeles
    Aurelia Syngkon
    Victoria Liublinska
    Konstantin Ichtchenko
    Philip Band
    Scientific Reports, 6
  • [9] The basis of receptor recognition by botulinum neurotoxin B
    Nature Clinical Practice Urology, 2007, 4 (3): : 118 - 119
  • [10] Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B
    Flores, Alessandra
    Ramirez-Franco, Jorge
    Desplantes, Richard
    Debreux, Kevin
    Ferracci, Geraldine
    Wernert, Florian
    Blanchard, Marie-Pierre
    Maulet, Yves
    Youssouf, Fahamoe
    Sangiardi, Marion
    Iborra, Cecile
    Popoff, Michel Robert
    Seagar, Michael
    Fantini, Jacques
    Leveque, Christian
    El Far, Oussama
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (36) : 18098 - 18108
12345